Supplemental Materials for Joseph Merola et al. Efficacy And Safety Of Apremilast In Patients With Moderate-To-Severe Genital Psoriasis: Results From Discreet, A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial

Name: Supplemental Materials for Joseph Merola et al. Efficacy And Safety Of Apremilast In Patients With Moderate-To-Severe Genital Psoriasis: Results From Discreet, A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial
Creator: Joseph Merola
Published: 2023-10-13T15:48:10.782Z
Keywords: Clinical Trial, Safety, Therapeutics, Controlled Clinical Trial, Psoriasis, Quality of Life

Merola, Joseph; Parish, Lawrence C; Lynde, Charles; Guenther, Lyn; Lacour, Jean-Philippe; Staubach, Petra; Cheng, Sue; Paris, Maria; Picard, Hernan; Deignan, Cynthia; Jardon, Shauna; Chen, Mindy; Papp, Kim

doi:10.17632/dhtrp945bn.2

Supplemental Materials for Joseph Merola et al. Efficacy And Safety Of Apremilast In Patients With Moderate-To-Severe Genital Psoriasis: Results From Discreet, A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial

Published: 13 October 2023| Version 2 | DOI: 10.17632/dhtrp945bn.2

Contributors:

Joseph Merola, Lawrence C Parish, Charles Lynde, Lyn Guenther, Jean-Philippe Lacour, Petra Staubach, Sue Cheng, Maria Paris, Hernan Picard, Cynthia Deignan, Shauna Jardon, Mindy Chen, Kim Papp

Description

Mendeley Supplemental Figures for Joseph Merola et al. Efficacy And Safety Of Apremilast In Patients With Moderate-To-Severe Genital Psoriasis: Results From Discreet, A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial. J Am Acad Dermatol. 2023.

Supplemental Materials for Joseph Merola et al. Efficacy And Safety Of Apremilast In Patients With Moderate-To-Severe Genital Psoriasis: Results From Discreet, A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial

Description

Files

Categories

Licence